Literature DB >> 17365619

Adderall abuse in Texas, 1998-2004.

Mathias B Forrester1.   

Abstract

Adderall is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and is subject to abuse. This study describes the patterns of Adderall abuse calls received by several poison control centers in Texas during 1998-2004. Drug abuse calls were assessed by call year and geographic location. Drug abuse calls were then compared to all other human exposure (nonabuse) calls with respect to various factors. Of all Adderall exposure calls, 12% involved abuse. The number of drug abuse calls received per year increased during the first part of 7-yr period but then declined. Male patients accounted for almost 60% of both drug abuse and nonabuse calls. Adolescent patients comprised 69% of drug abuse calls and children less than 13 yr old comprised 66% of nonabuse calls. Although the majority of both types of human exposures occurred at the patient's own residence, drug abuse calls were more likely than nonabuse calls to involve exposures at another residence (6% vs. 3%), school (22% vs. 5%) and public areas (2% vs. 0.4%). Drug abuse calls were less likely than nonabuse calls to be managed outside of a health care facility (18% vs. 51%) and to be classified as no adverse effect (23% vs. 48%). Adderall abusers are more likely to be adolescents. Adderall abuse as compared to other exposures is more likely to occur outside of the person's home and involve more serious medical outcomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17365619     DOI: 10.1080/15287390600974619

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  3 in total

1.  Prescription psychostimulant abuse.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2007-09

Review 2.  How addictive drugs disrupt presynaptic dopamine neurotransmission.

Authors:  David Sulzer
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

3.  Surveillance of diversion and nonmedical use of extended-release prescription amphetamine and oral methylphenidate in the United States.

Authors:  Mark A Sembower; Michelle D Ertischek; Chloe Buchholtz; Nabarun Dasgupta; Sidney H Schnoll
Journal:  J Addict Dis       Date:  2013
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.